Lipo Laser (Laser Lipo): What It Is, Does It Work and Cost

"Laser lipo" can mean three different things, and they are not interchangeable.

Each FDA clearance we reviewed names a specific device and its cleared use; for this guide we sort the devices and procedures the name is used for into three groups, each with its own clearance, evidence and price:

• Low-level laser devices — Erchonia's Zerona and i-Lipo are examples of the devices in this group. In the clearance wording we reviewed, this is a non-invasive dermatological aesthetic treatment for the reduction of body circumference — a tape-measure outcome, and explicitly not fat loss or weight loss. Erchonia's ML Scanner was the first, cleared through FDA's de novo pathway on August 24, 2010; current models such as the Zerona VZ8 (clearance K243811, January 10, 2025) are cleared for over-the-counter use.
• Heat-based laser fat reduction — SculpSure (Cynosure) is a 1060 nm laser first cleared on May 15, 2015 for non-invasive lipolysis of the flanks in people with BMI 30 or less; later clearances expanded its areas.
• Laser-assisted liposuction — in our grouping, the surgical option: a procedure in which a laser fiber is passed under the skin. We did not review clearance records for the surgical devices, so treat this third group as a different kind of treatment, not a stronger version of the first.

Low-level lasers are one of several non-surgical body contouring options, alongside devices that use cold on fat, like CoolSculpting, or heat, like SculpSure.

The FDA records we reviewed for these devices describe what they are cleared to do, not how they work.

The Zerona VZ8 clearance describes "a non-invasive dermatological aesthetic treatment for the reduction of body circumference," and covers distribution for over-the-counter use.

The wording matters, because it differs from the fat-reduction clearances.

CoolSculpting's current clearance covers "cold-assisted lipolysis (breakdown of fat)" of named areas, and SculpSure's original clearance covers "non-invasive lipolysis" through the "disruption of adipocyte cells" — fat cells.

The low-level laser clearances we reviewed say nothing about fat cells; they speak of circumference alone.

What we cannot give you is a mechanism.

Our sources describe the cleared use and the measured outcomes, not a biological pathway, so any confident explanation of what the laser "does to fat cells" goes beyond the documents we reviewed.

Ask any office for the device's brand and model, and read its clearance before you book.

The over-the-counter detail deserves a pause of its own.

Current Zerona models — the VZ8 among them — are cleared for over-the-counter distribution; our sources do not say whether other brands' models in this group carry the same wording.

The nickname on the brochure does not tell you which of the three treatments is actually on offer, and in the records we reviewed each clearance names a specific model — the VZ8's K243811, for example.

So the useful question at any office is which model is in the room, and what that model's own clearance says.

The evidence base is small.

A 2025 systematic review in the journal Lasers in Medical Science found only three randomized controlled trials of low-level laser therapy for body circumference, with 160 participants in total.

Across those trials, waist circumference fell by 2.48 cm with the laser treatment versus 0.64 cm in the control groups.

The review's authors noted that protocols varied between the trials and that long-term efficacy is unclear.

Two things follow.

First, those figures are trial averages from 160 people across three small studies — not a prediction for any individual.

Second, the changes being measured are centimeters on a tape measure: the effects reported in the small trials we reviewed sit in the 2 to 4 cm range.

That is the scale of what is documented — a modest change in measurement, not a transformation.

One detail in the review deserves attention: the control groups moved too.

Waist circumference fell by 0.64 cm in the groups that did not receive the laser treatment, which is why the 2.48 cm figure has to be read against that comparison rather than on its own.

And on duration, the review could not establish that any change holds — the authors called long-term efficacy unclear, and the clearance wording we reviewed names an aesthetic reduction of body circumference with no duration attached.

Start with what we could not find: a national price.

Our research turned up no government, society or peer-reviewed figure for low-level laser body treatments that we can quote, and we would rather say that than print an average we cannot stand behind.

What our research does support is that which of the three treatments is being quoted comes before any price does: low-level laser sessions, heat-based SculpSure-style lipolysis and laser-assisted liposuction are three different purchases, and quotes are not comparable until you know which one you are getting.

The mixing problem runs in both directions.

A quote for a non-invasive treatment and a quote for surgery describe different purchases, and neither compares cleanly with a heat-based laser quote.

The only like-for-like comparison is between quotes for the same device category — ideally the same model — covering the same number of visits and measured the same way.

• Which device — brand and model — will be used, and what its FDA clearance covers.
• Whether the price is per session or covers a series, and what each visit includes.
• How many visits the office advises for the result it describes, and how results will be measured — for the cleared low-level laser use, the measure is body circumference.
• What the total comes to in writing, and what the office considers a realistic outcome.

The price conversation is also the moment to check expectations.

The effects documented in the trials we reviewed were centimeters of circumference, so a quote that promises specific inch loss or frames the treatment as weight loss does not match the device's cleared use.

Here we have to be straightforward about a gap: our research did not surface side-effect rates for low-level laser body devices from a source we can quote.

The clearance records we reviewed describe the cleared use, and the 2025 review's reported results cover waist measurements and long-term uncertainty.

Neither gave us side-effect rates we can quote.

Absence of a number is not absence of risk — it means this page cannot put figures on the section, and the office you are considering is the right place to ask.

• The cleared use is non-invasive: the device works from outside the body. That describes the category, not the comfort or recovery of any one session.
• The heat-based laser category uses heat on fat; the low-level laser devices are a separate group, so a safety answer about one category does not transfer to the other.
• Laser-assisted liposuction is the surgical group described earlier — a laser fiber passed under the skin — so the relevant risk questions are surgical ones, and they belong to the practice that would perform it.

It also helps to know what a clearance is, because the word gets stretched in marketing.

A clearance states what FDA allows a device to be sold for; it is not a report on what patients experienced in practice, an assessment of any one office's technique, or a promise of a result.

That is exactly why the questions in the last section belong to the office that knows its own machine.

CoolSculpting is the cold-based option — "cold-assisted lipolysis (breakdown of fat)" in its clearance.

The brand began with Zeltiq and now sits with Allergan Aesthetics.

It was first cleared for fat reduction via de novo DEN090002 on August 24, 2010, and the current CoolSculpting Elite clearance (K233732, September 12, 2024) covers cold-assisted lipolysis of the upper arm, bra fat, back fat, banana roll, thigh, abdomen and flank at BMI 30 or less, and the submental/submandibular area under the chin at BMI up to 46.2.

In cleared language it is a treatment for visible fat bulges in specific areas — not weight loss.

The differences from low-level laser lipo are in the documents.

CoolSculpting's clearance names fat — lipolysis, the breakdown of fat cells — in listed areas, with BMI ceilings stated.

SculpSure, the heat-based laser our guide also groups under the "laser lipo" name, was first cleared on May 15, 2015 (K150230) for non-invasive lipolysis of the flanks at BMI 30 or less, with later clearances expanding its areas.

The low-level laser clearances we reviewed name no fat outcome.

Different clearances describe different outcomes — and, in practice, they set up different price conversations.

For CoolSculpting's own details — sessions, cost and side effects — see CoolSculpting.

Search "lipo laser near me" and the results can mix the three groups described in this guide: offices with low-level laser devices, offices selling heat-based lipolysis sessions, and surgical practices offering laser-assisted liposuction.

The clearing questions are the same either way, and they are worth asking before money changes hands.

Two of our guides take those questions further: how to choose a med spa is the checklist we would use before booking any treatment, and injector credentials explains what each license — RN, NP, PA, MD — means for who treats you.